Animal Biotechnology is a specialized domain within biotechnology that leverages molecular biology techniques for the genetic modification of animals. The primary goal is to optimize their traits for pharmaceutical, agricultural, or industrial purposes. This application extends to the creation of genetically modified animals with improved growth rates, disease resistance, and the ability to produce therapeutic proteins. Utilizing advanced genetic and cellular methodologies, Animal Biotechnology encompasses genetic engineering, cloning, and reproductive technologies, contributing significantly to advancements in agriculture, medicine, and conservation.
However, the field faces ethical, legal, and societal challenges, and these aspects are central to discussions at conferences. These gatherings provide a platform for experts to engage in discussions, exchange cutting-edge research, and present a visionary outlook for the future of Animal Biotechnology. Through these conferences, the narrative of the field unfolds, addressing both the potential benefits and the ethical considerations associated with genetical modifications in animals.
Major areas of Animal Biotechnology includes:
- Molecular Biology
- Animal Cell culture & Stem Cell Biology
- Toxicology
- Animal Reproduction
- Breeding and Transgenic Technology
- Genetic Engineering
Yong Xiao Wang
Albany Medical College, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Bernd Blobel
University of Regensburg, Germany
Huiqin Yang
ICON Clinical Research Ltd, United Kingdom
Srividya Narayanan
Northeastern University, United States
Maria Richards Brown
University College London, United Kingdom
Rassa Pegahi
UPSA, France
Hanieh Khalili
University of East London, United KingdomSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia